Nonclinical Safety Assessment (ePub)
A Guide to International Pharmaceutical Regulations
(Sprache: Englisch)
Nonclinical Safety Assessment
Nonclinical Safety Assessment
A Guide to International Pharmaceutical Regulations
Bringing a new drug to market is a costly time-consuming process. Increased regional and international regulation over the last twenty...
Nonclinical Safety Assessment
A Guide to International Pharmaceutical Regulations
Bringing a new drug to market is a costly time-consuming process. Increased regional and international regulation over the last twenty...
sofort als Download lieferbar
eBook (ePub)
136.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „Nonclinical Safety Assessment (ePub)“
Nonclinical Safety Assessment
Nonclinical Safety Assessment
A Guide to International Pharmaceutical Regulations
Bringing a new drug to market is a costly time-consuming process. Increased regional and international regulation over the last twenty years, while necessary, has only served to amplify these costs. In response to this escalation, developmental strategies have shifted towards a more global approach. In order to create the most cost-effective and safe processes, it is critical for those bringing drugs to market to understand both the globally accepted regulations and the local variations. Nonclinical Safety Assessment: A Guide to International Pharmaceutical Regulations provides a practical description of nonclinical drug development regulations and requirements in the major market regions.
It includes:
* ICH - the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
* National regulations, including US FDA, Canada, Mercosur and Brazil, South Africa, China, Japan, India and Australia
* Repeated dose toxicity studies
* Carcinogenicity; Genotoxicity; Developmental and reproductive toxicology; Immunotoxicology
* Biotechnology-derived pharmaceuticals
* Vaccine development
* Phototoxicity and photocarcinogenicity
* Degradants, impurities, excipients and metabolites
Primarily intended for those professionals actively involved in the nonclinical and clinical development of a pharmaceutical product, including toxicologists, pharmacologists, clinicians and project managers, this book provides a roadmap for successful new drug approval and marketing.
Nonclinical Safety Assessment
A Guide to International Pharmaceutical Regulations
Bringing a new drug to market is a costly time-consuming process. Increased regional and international regulation over the last twenty years, while necessary, has only served to amplify these costs. In response to this escalation, developmental strategies have shifted towards a more global approach. In order to create the most cost-effective and safe processes, it is critical for those bringing drugs to market to understand both the globally accepted regulations and the local variations. Nonclinical Safety Assessment: A Guide to International Pharmaceutical Regulations provides a practical description of nonclinical drug development regulations and requirements in the major market regions.
It includes:
* ICH - the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
* National regulations, including US FDA, Canada, Mercosur and Brazil, South Africa, China, Japan, India and Australia
* Repeated dose toxicity studies
* Carcinogenicity; Genotoxicity; Developmental and reproductive toxicology; Immunotoxicology
* Biotechnology-derived pharmaceuticals
* Vaccine development
* Phototoxicity and photocarcinogenicity
* Degradants, impurities, excipients and metabolites
Primarily intended for those professionals actively involved in the nonclinical and clinical development of a pharmaceutical product, including toxicologists, pharmacologists, clinicians and project managers, this book provides a roadmap for successful new drug approval and marketing.
Autoren-Porträt
EditorsWilliam J. Brock Brock Scientific Consulting, Montgomery Village, USA
Kenneth L. Hastings Sanofi, Bethesda, USA
Kathy M. McGown FoxKiser, USA
Bibliographische Angaben
- 2013, 1. Auflage, 488 Seiten, Englisch
- Herausgegeben: William J. Brock, Kenneth L. Hastings, Kathy M. McGown
- Verlag: John Wiley & Sons
- ISBN-10: 1118516982
- ISBN-13: 9781118516980
- Erscheinungsdatum: 05.03.2013
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: ePub
- Größe: 2.61 MB
- Mit Kopierschutz
Sprache:
Englisch
Kopierschutz
Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.
Kommentar zu "Nonclinical Safety Assessment"
Schreiben Sie einen Kommentar zu "Nonclinical Safety Assessment".
Kommentar verfassen